In general, research supports the idea that NF-κB largely acts as a pro-carcinogenesis factor in various types of cancer, and modulating its expression could potentially be a useful approach for cancer treatment (Pakjoo et al., 2024; Ebrahimi et al., 2024). Here, NFKB1 is linked to cancer.